Health Bulletin 13/August/2022 Roshni Dhar13 Aug 2022 5:20 PM ISTHere are the top health stories for the day:With strict bond terms, Rajasthan in-service PG medicos facing trouble getting study leaveWith the State...
Mired in controversy, JNJ baby powder to go off shelves from 2023 Ruchika Sharma13 Aug 2022 2:00 PM ISTThe company faces about 38,000 lawsuits from consumers and their survivors claiming its talc products caused cancer due to contamination with...
Mathai Mammen leaves position as JnJ Executive Vice President, Pharmaceuticals, RnD Ruchika Sharma12 Aug 2022 3:00 PM ISTNew Brunswick: Johnson & Johnson has announced that Mathai Mammen, M.D., Ph.D., has decided to leave his position as Executive Vice...
Johnson and Johnson cancer drug sales help weather hit from stronger dollar Ruchika Sharma20 July 2022 2:00 PM ISTThe company said it was raising prices of some products like painkillers and mouthwash in response to inflation.
Janssen Pharma gets USFDA Breakthrough Therapy Designation for Multiple Myeloma treatment Talquetamab Ruchika Sharma30 Jun 2022 3:02 PM ISTTalquetamab is an investigational, off-the-shelf, T-cell redirecting bispecific antibody targeting both GPRC5D, a novel drug target, on multiple...
WHO gives nod to Biological E as additional production site for JnJ COVID vaccine Ruchika Sharma23 Jun 2022 4:30 PM ISTIndia's first indigenously developed RBD protein subunit vaccine, Biological E's Corbevax, is currently being used to inoculate children in the age...
Phase 3 SHINE results show postive results for IMBRUVICA (ibrutinib) in Mantle Cell Lymphoma Ruchika Sharma5 Jun 2022 3:00 PM ISTMCL is a type of aggressive, rare non-Hodgkin lymphoma (NHL) that is incurable and difficult to treat.
Patent infringement: JnJ, Momenta Pharma file case against Natco, Mylan Pharma Ruchika Sharma26 May 2022 3:54 PM ISTHyderabad: Johnson & Johnson's and Momenta Pharmaceuticals have filed a lawsuit against Natco Pharma and its marketing partner Mylan...
Coronavirus: India supplies non-JnJ vaccine under Quad umbrella Ruchika Sharma21 May 2022 10:00 AM ISTBagchi did not give numbers, but Indian foreign ministry data shows that India last month sent 200,000 doses of Covovax, a version of the Novavax...
Blood clot risk - USFDA limits use of JnJ COVID vaccine Ruchika Sharma6 May 2022 12:54 PM ISTThe vaccine maker said it has updated the U.S. COVID-19 vaccine fact sheet to warn about the risk of thrombosis with thrombocytopenia syndrome (TTS),...
JnJ suspends sales forecast for COVID vaccine Ruchika Sharma20 April 2022 12:09 PM ISTJnJ said it now expects full-year adjusted profit forecast to be between $10.15 and $10.35 per share, lower than the prior forecast of $ 10.40 to $...
J&J unit proposes independent exam if it remains in bankruptcy Ruchika Sharma20 Feb 2022 9:00 AM ISTNew Delhi: A Johnson & Johnson subsidiary proposed on Friday that it would submit to an independent examination of the corporate...
